Development of mercapto-phenyl-1,2,4-triazole bearing thio-quinoline as a novel class of tyrosinase inhibitors: an in vitro and in silico study
Abstract
In this study, a novel series of mercapto-phenyl-1,2,4-triazole-bearing thio-quinoline moieties was designed, synthesized, and evaluated for their anti-tyrosinase activities. All compounds were tested for inhibitory activity against tyrosinase, compound 12j was found to be the most potent with IC 50 = 10.49 ± 1.02 µM. Structure–activity relationship (SAR) analysis indicated that the introduction of electron-donating and electron-withdrawing groups at specific positions influenced the inhibitory efficacy. The antioxidant activity of all derivatives were also performed, and 12j showed IC 50 = 102.36 ± 3.33 µM. In silico molecular docking studies showed that compound 12j had the strongest binding affinity (binding energy = − 8.04 kcal/mol) and formed stable hydrogen bonds with key active site residues (e.g., His85, His259, and His296) of tyrosinase. Molecular dynamics simulations have further exhibited the high stability and compactness of the 12j –tyrosinase complex, with minimum RMSD fluctuations and stable hydrogen bonding patterns. These results suggest the potency of these derivatives as promising tyrosinase inhibitors with useful information into their mechanism, establishing a foundation for future therapeutic applications in hyperpigmentation and related disorders.
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in cell cultures (in vitro) and computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.